Proliferative Vitreoretinopathy Clinical Trial
Official title:
Repeated Intra-silicone Oil Injection of Methotrexate for Management of Proliferative Vitreoretinopathy Grade C; A Multi-center Study
This multicenter randomized clinical trial evaluates the effect of multiple intra-silicone
oil injections of methotrexate (MTX) on rhegmatogenous retinal detachment (RRD) with grade C
proliferative vitreoretinopathy (PVR).
74 eyes with the diagnosis of RRD with PVR grade C will be randomized into two groups: the
intervention group and the control group. All eyes undergo pars plana vitrectomy(PPV) and
intraocular injection of silicone oil (SO). At the end of the surgical procedure, intra-SO
injection of 250 µg MTX will be performed in the intervention group. No intra-SO injection
will be done in the control group. In the intervention group, Intra-SO injection of MTX will
be repeated at 3 and 6 weeks postoperatively. Silicone oil removal will be done 3 months
after surgery.Spectral-domain optical coherence tomography (SD-OCT) image of the macula will
be acquired at months 3 and 6. The retinal reattachment rate at months 6 will be assessed as
the main outcome measure of the study. Best corrected visual acuity, retinal reproliferation
rate and adverse events are the secondary outcome measures. Comprehensive ocular examination
will be performed at weeks 1, 3, 6 and at months 3, 4 and 6.
n/a
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT05561569 -
Air Versus Gas Tamponade in Primary Retinal Detachment
|
N/A | |
| Not yet recruiting |
NCT05538156 -
Internal Limiting Membrane Peeling in Retinal Detachment Surgery
|
N/A | |
| Completed |
NCT01445028 -
Isotretinoin for Proliferative Vitreoretinopathy
|
Phase 4 | |
| Recruiting |
NCT00370760 -
Oral Colchicine Combined With Intravitreal Infusion of Dexamethasone, LMW Heparin and 5-FU for Management of Proliferative Vitreoretinopathy (PVR)
|
Phase 3 | |
| Completed |
NCT00000140 -
The Silicone Study
|
Phase 3 | |
| Completed |
NCT06166914 -
Efficacy of 5-fluorouracil and Low Molecular Weight Heparin in High-risk Pediatric Retinal Detachment
|
N/A | |
| Recruiting |
NCT04580147 -
Intravitreal Aflibercept for the Prevention of Proliferative Vitreoretinopathy Following Retinal Detachment Repair
|
Phase 2 | |
| Completed |
NCT04891991 -
Intravitreal Infliximab for Proliferative Vitreoretinopathy
|
Phase 2 | |
| Completed |
NCT01255293 -
Comparative Study of 1000 Centistoke Versus 5000 Centistoke Silicone Oil for Repair of Complex Retinal Detachments
|
N/A | |
| Completed |
NCT04136366 -
The GUARD Trial - Part 1: A Phase 3 Clinical Trial for Prevention of Proliferative Vitreoretinopathy
|
Phase 3 | |
| Recruiting |
NCT06289205 -
"Comparing Methotrexate Usage Techniques to Prevent Proliferative Vitreoretinopaty After Retinal Detachment Vitrectomy"
|
Phase 1/Phase 2 | |
| Completed |
NCT00373282 -
Triamcinolone Acetonide in Silicone-Filled Eyes as Adjunctive Treatment for Proliferative Vitreoretinopathy
|
Phase 3 | |
| Completed |
NCT01995045 -
Postoperative Pain Control Following Vitreoretinal Surgery
|
Phase 4 | |
| Completed |
NCT04490876 -
Outcomes of Extensive Brilliant Blue G-Assisted Internal Limiting Membrane Peeling in Proliferative Vitreoretinopathy
|
||
| Completed |
NCT02192970 -
Bevacizumab Against Recurrent Retinal Detachment
|
Phase 2 | |
| Not yet recruiting |
NCT04682054 -
Molecular Taxonomy of Surgically-harvested Ocular Tissues Defined by Single-cell Transcriptomics
|
N/A | |
| Recruiting |
NCT05660447 -
A Multi-Center Study on the Use of Rho-Kinase Inhibitor to Reduce or Prevent PVR in RRD Eyes at High Risk for PVR
|
Phase 2/Phase 3 | |
| Not yet recruiting |
NCT06033703 -
Topical Netarsudil for the Prevention of Proliferative Vitreoretinopathy in Patients With Retinal Detachment
|
Phase 1/Phase 2 | |
| Active, not recruiting |
NCT00371020 -
The Effect of 5-FU and LMW Heparin on the Rate of Retinal Redetachment After Silicone Oil Removal in Cases of PVR
|
Phase 3 | |
| Completed |
NCT03727776 -
Adrenocorticotropic Hormone (ACTH) for Post-op Inflammation in Proliferative Vitreoretinopathy (PVR)
|
Early Phase 1 |